Allergan unveils new Botox plant ahead of $63B AbbVie merger

AbbVie will soon own Allergan’s prized Botox franchise, and along with its roughly $4 billion in sales, it will lay claim to a new $176 million plant at the site in Ireland where the blockbuster is exclusively produced.